Non invasive screening for pulmonary involvement in early RA Combination of PFT and Lung 🫁 US: -50% with interstitial or focal changes or pleural effusion on US -58% with abnormal DLCO Correlation w/ higher disease activity. Pathological meaning? @RheumNow ABST 0393 #ACR23 https://t.co/BBcOEgcJK2

@RheumNow PMR Mythbusters: we polled Aussie🇦🇺 rheumatologists How did those motivated enough to answer a PMR/GCA survey fare? Myth: PMR is only proximal - not bad Myth: PMR needs ⬆️ESR/CRP - a bit of work Time to #MakeRheumForPMR @victor_yang1 @CatherineL_Hill #ACR23 ABST0267 https://t.co/Z4ZkDHljOf https://t.co/ssHxOBJFxR

WEAR study: adherence to wearable activity trackers in RA Something that is consistent across all wearable studies is low adherence Here under 50% for PRO + tracking In an already selected population! To implement, we need to make this better? ABSTRACT 0344 @RheumNow #ACR23 https://t.co/csVZlzABGt

Difficult to treat D2T-axSpA (failure > 3 biologics), affects one in five patients exposed to b/tsDMARDs in this national registry. D2T is more common in women, presence of peripheral involvement, psoriasis, depression, Fakih O Abst#0514 #ACR23 @RheumNow https://t.co/OoymZzzQST https://t.co/EpTqS1C61A

Deucravacitinib (TYK2) data has been surprisngly good in SLE Strong rationale in PsA as well; I liked this poster & the focus on pain scores / patient QOL Probably my #1 draft pick for "drugs I'm buying right now" @RheumNow #ACR23 Abstr0508 https://t.co/FHNvgUrYxp

Year in Review: Dr. P Seo ⭐️Does Pizza consumption favor improved dz activity in RA? If in Italy ➡️ 365 pts w/RA in Milan: 18-65 yo w/ >3 mo dz ➡️Ate 1/2 a pizza > 1x/wk w/ decr in dz activity (SDAI⬇️: -3.6) ➡️Mozzarella & olive oil showed beneficial effects #ACR23 @RheumNow https://t.co/qZTzThI39e

YR in Review: Dr. P Seo ⭐️Sarilumab for relapse of PMR during GC taper: ➡️ab against IL6R ➡️118 pts: ⏺️pred 15 mg/d ⏺️Sari 200 mg/d q2wk/14wk ⏺️52wk pred taper ➡️At wk 52: ⏺️sustained remission: 28% vs 10% ⏺️mean total GC: 777 vs 2044 mg #ACR23 @RheumNow https://t.co/ETVpyuBlZ7

There is a high concordance (84.4%) of physician and patient global assessment of psoriatic arthritis disease activity from 538 paired assessments in the ARLAR multinational study, Maroof A et al, Abst #0506 #ACR23 @RheumNow https://t.co/NsT4MNWPVX https://t.co/TfuMj8qMXz

RA as a young woman used to mean kids were only a distant thought. Japanese RA pts n=280 asked whether RA onset meant wanting fewer children & why. Confidence improving across the board over time. We want to give our RA pts choices to live their life! #ACR23 ABST0473 @RheumNow https://t.co/OHZM2J5qxS

Tired of getting referrals for symptomatic patients with 1/80+ ANAs antibodies? This new risk model for systemic AID is very welcome! Variables: age, female, higher ANA titer, higher platelet count, disease-specific autoantibody & billing code count. #ACR23 @Rheumnow ABST0131 https://t.co/q8rYjjtZ89